Home » FDA Approves Novo Nordisk Hemophilia A Drug
FDA Approves Novo Nordisk Hemophilia A Drug
The FDA has granted Novo Nordisk a clear path for its biologics license for the hemophilia A drug Novoeight.
Pharma Times
Pharma Times
Upcoming Events
-
07May
-
14May
-
30May